Aisling Capital LLC 13F Holdings · last filed Q3 2019
Aisling Capital LLC reported 5 securities worth $45.28M in its SEC 13F filing for Q3 2019 (period ended 2019-09-30). Top holdings: AIMT (57.34%), ADMA (35.46%), CDTX (3.93%). Among its top 25 positions this quarter: 1 new, 2 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AIMT | AIMMUNE THERAPEUTICS INC. | $26.0M | 57.34% | 1.2M | Trimmed |
| 2 | ADMA | ADMA BIOLOGICS INC | $16.1M | 35.46% | 3.6M | Hold |
| 3 | CDTX | CIDARA THERAPEUTICS INC. | $1.8M | 3.93% | 891,614 | Trimmed |
| 4 | ASXC | TRANSENTERIX INC. | $1.5M | 3.27% | 2.4M | Hold |
| 5 | VRAYQ | VIEWRAY INC. | $0 | 0.00% | 18,964 | New |
Source: SEC Form 13F filings · as of 2019-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR